Cytokinetics
CYTK
#1823
Rank
โ‚น1.119 T
Marketcap
โ‚น8,245
Share price
-0.08%
Change (1 day)
189.06%
Change (1 year)

Market capitalization of Cytokinetics (CYTK)

Market cap: โ‚น1.119 Trillion

As of July 2026 Cytokinetics has a market cap of โ‚น1.119 Trillion. This makes Cytokinetics the world's 1823th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Cytokinetics from 2004 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚น1.119 T61.6%
2025โ‚น692.67 B44.47%
2024โ‚น479.47 B-29.65%
2023โ‚น681.51 B89.94%
2022โ‚น358.80 B25.32%
2021โ‚น286.31 B166.18%
2020โ‚น107.56 B140.26%
2019โ‚น44.77 B85.15%
2018โ‚น24.18 B-13.77%
2017โ‚น28.04 B-16.38%
2016โ‚น33.53 B21.88%
2015โ‚น27.51 B40.19%
2014โ‚น19.62 B59.29%
2013โ‚น12.32 B139.33%
2012โ‚น5.14 B40.25%
2011โ‚น3.67 B-41.42%
2010โ‚น6.26 B-24.26%
2009โ‚น8.27 B20.94%
2008โ‚น6.84 B-25.22%
2007โ‚น9.14 B-36.2%
2006โ‚น14.33 B81.5%
2005โ‚น7.90 B-33.7%
2004โ‚น11.91 B

End of Day market cap according to different sources

On Jul 5th, 2026 the market cap of Cytokinetics was reported to be:

โ‚น1.026 Trillion
by Nasdaq info icon info icon
โ‚น1.120 Trillion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Amgen
AMGN
โ‚น18.804 T 1,579.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Trevena
TRVN
โ‚น0.9 M-100.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
โ‚น609.59 B-45.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
โ‚น78.32 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Array Technologies
ARRY
โ‚น102.42 B-90.85%๐Ÿ‡บ๐Ÿ‡ธ USA